Medium urgency

IL HB0001: HEMP CANNABINOIDS-MINORS

Detected August 25, 2026 · in Dietary-Supplement Labeling (FDA)

Illinois House Bill 1 (IL HB0001) introduces new restrictions on the sale of hemp-derived cannabinoid products to minors, requiring age verification and potentially affecting labeling and marketing practices for dietary supplements containing hemp-derived ingredients.

Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on August 25, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers that produce or sell hemp-derived cannabinoid products (e.g., CBD) in Illinois. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the excerpt; check the bill text for the effective date.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

The bill imposes new requirements to prevent sales of hemp cannabinoid products to minors, likely including age verification at point of sale and possibly restrictions on packaging, labeling, or marketing that appeals to minors.

Who it affects

Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers that produce or sell hemp-derived cannabinoid products (e.g., CBD) in Illinois.

What you must do

Review the full text of IL HB0001 to understand specific requirements (e.g., age verification processes, labeling changes) and implement compliance measures before the effective date.

Deadline

Not specified in the excerpt; check the bill text for the effective date.

Source: https://ilga.gov/Legislation/RegularSession/HB?SessionId=114

Never miss a change like this again

Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Dietary-Supplement Labeling (FDA)